AHPIQ Statistics
Total Valuation
Allied Healthcare Products has a market cap or net worth of 401.
| Market Cap | 401 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Allied Healthcare Products has 4.01 million shares outstanding.
| Shares Outstanding | 4.01M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.69, with a Debt / Equity ratio of 202.09.
| Current Ratio | 2.69 |
| Quick Ratio | 0.95 |
| Debt / Equity | 202.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.54 |
| Interest Coverage | -23.92 |
Financial Efficiency
Return on equity (ROE) is -67.81% and return on invested capital (ROIC) is -20.10%.
| Return on Equity (ROE) | -67.81% |
| Return on Assets (ROA) | -15.32% |
| Return on Capital (ROIC) | -20.10% |
| Revenue Per Employee | 185,251 |
| Profits Per Employee | -36,722 |
| Employee Count | 146 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 2.74 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is 33.27, so Allied Healthcare Products's price volatility has been higher than the market average.
| Beta (5Y) | 33.27 |
| 52-Week Price Change | -66.67% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.15 |
| Relative Strength Index (RSI) | 48.16 |
| Average Volume (20 Days) | 3,621 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, Allied Healthcare Products had revenue of 27.05 million and -5.36 million in losses. Loss per share was -1.34.
| Revenue | 27.05M |
| Gross Profit | 2.53M |
| Operating Income | -4.58M |
| Pretax Income | -4.76M |
| Net Income | -5.36M |
| EBITDA | -4.13M |
| EBIT | -4.58M |
| Loss Per Share | -1.34 |
Balance Sheet
The company has 3.32 million in cash and 10.58 million in debt, giving a net cash position of -7.26 million or -1.81 per share.
| Cash & Cash Equivalents | 3.32M |
| Total Debt | 10.58M |
| Net Cash | -7.26M |
| Net Cash Per Share | -1.81 |
| Equity (Book Value) | 5.23M |
| Book Value Per Share | 1.30 |
| Working Capital | 10.10M |
Cash Flow
In the last 12 months, operating cash flow was -4.10 million and capital expenditures -75,036, giving a free cash flow of -4.17 million.
| Operating Cash Flow | -4.10M |
| Capital Expenditures | -75,036 |
| Free Cash Flow | -4.17M |
| FCF Per Share | -1.04 |
Margins
Gross margin is 9.34%, with operating and profit margins of -16.93% and -19.82%.
| Gross Margin | 9.34% |
| Operating Margin | -16.93% |
| Pretax Margin | -17.61% |
| Profit Margin | -19.82% |
| EBITDA Margin | -15.27% |
| EBIT Margin | -16.93% |
| FCF Margin | -15.42% |
Dividends & Yields
Allied Healthcare Products does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.32% |
| Shareholder Yield | 0.32% |
| Earnings Yield | -1,340,000.00% |
| FCF Yield | -1,039,330.65% |
Stock Splits
The last stock split was on December 7, 2016. It was a reverse split with a ratio of 0.5.
| Last Split Date | Dec 7, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.5 |
Scores
Allied Healthcare Products has an Altman Z-Score of 0.44. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.44 |
| Piotroski F-Score | n/a |